Terpenes – Pharmaceutics and Biotechnology
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (1 November 2021) | Viewed by 23088
Special Issue Editors
Interests: natural products; cancer; inflammation; endoplasmic reticulum; proteostasis
Interests: natural products chemistry; bioactive small molecules; anti-inflammatory drugs; pro-apoptotic drugs; endoplasmic reticulum stress; proteasome inhibitors
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In the ever-evolving field of pharmaceuticals, terpenes and its derivatives have been playing a remarkable role as effective therapeutic solutions, which include the antimalaric artemisinin, the anticancer drug paclitaxel, or the vaccine adjuvant squalene. This special issue will focus in the therapeutic application of terpenes and derivatives, and on their production using different biotechnological approaches.
The growing knowledge on the biological potential of terpenes and derivatives, driving new therapeutic strategies, is the focus of this Special Issue. The focus will be on research articles and reviews on sustainable approaches to produce terpenes, development and characterization of innovative formulations, on the stability and safety of terpene solutions, pharmacokinetic and pharmacodynamic profiles, and pharmacological investigation. Other technological or pharmaceutical aspects will also be welcome.
Dr. João Carlos Salvador Fernandes
Dr. David M. Pereira
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Biotechnology
- Terpenes
- Pharmaceutics
- Biosynthesis
- Synthetic biology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.